Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination

Sputum examination is being used increasingly as a noninvasive method to assess airway inflammation. Expectorated sputum has variable contamination with saliva. Methods of processing have included the selection of portions of the sample considered to be representative of pulmonary origin versus use of the whole specimen, which is confounded by varying volumes of saliva. We compared cell profiles and eosinophilic cationic protein (ECP) concentration in sputum selected from the expectorate and in the usually discarded residual portion to determine to what degree salivary contamination is minimized and if the results are representative of lower respiratory secretions. Sputum was induced with hypertonic saline in six healthy and nine asthmatic subjects. All portions considered to be of pure lower respiratory tract origin were selected from the residual. The selected and residual portions were treated with dithiothreitol, total cell counts and cell viability were obtained, cytospins were made for differential cell counts and supernatant was collected for ECP assay. Selected portions of the specimens, in comparison with the residual portion showed: little squamous cell contamination (median 1.2 vs 70%; p < 0.001); higher total cell counts.mL-1 (5.1 vs 0.5 x 10(6) cells.mL-1; p < 0.001); higher number of viable nonsquamous cells per sample (1.9 vs 0.6 x 10(6) cells; p < 0.001); higher slide quality score (7 vs 4; p < 0.001); and higher levels of ECP (768 vs 136 micrograms.L-1; p < 0.001). There were no differences in the differential cell counts of eosinophils (1.3 vs 3.8%), neutrophils (44 vs 32%), and lymphocytes (0.6 vs 0.6%). While the proportion of macrophages was lower (36 vs 54%; p < 0.05), the absolute number (41 vs 19 x 10(4) cells; p < 0.05) was higher in the selected portion. In summary, selection of all portions of induced sputum from the expectorate minimized the confounding influence of saliva. Loss of nonsquamous cells in the residual portion was variable but usually less than one third of those in the selected portion. With one exception, this loss had little influence on the differential counts of inflammatory cells. Similar observations apply to eosinophilic cationic protein levels. We conclude that, in healthy subjects and treated asthmatics, inflammatory markers in the selected portion of the expectorate can be used to represent those in the lower respiratory tract in general.

This article has been cited by other articles:

				J B Morjaria, A J Chauhan, K S Babu, R Polosa, D E Davies, and S T Holgate The role of a soluble TNF{alpha} receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial Thorax, July 1, 2008; 63(7): 584 - 591. [Abstract] [Full Text] [PDF]

				E. M. Erin, G. R. Jenkins, O. M. Kon, A. S. Zacharasiewicz, G. C. Nicholson, H. Neighbour, R. C. Tennant, A. J. Tan, B. R. Leaker, A. Bush, et al. Optimized Dialysis and Protease Inhibition of Sputum Dithiothreitol Supernatants Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 132 - 141. [Abstract] [Full Text] [PDF]

				L. Jayaram, M. M. Pizzichini, R. J. Cook, L-P. Boulet, C. Lemiere, E. Pizzichini, A. Cartier, P. Hussack, C. H. Goldsmith, M. Laviolette, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur. Respir. J., March 1, 2006; 27(3): 483 - 494. [Abstract] [Full Text] [PDF]

				E Truyen, L Coteur, E Dilissen, L Overbergh, L J Dupont, J L Ceuppens, and D M A Bullens Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients Thorax, March 1, 2006; 61(3): 202 - 208. [Abstract] [Full Text] [PDF]

				D.W. Reid, Q.T. Lam, H. Schneider, and E.H. Walters Airway iron and iron-regulatory cytokines in cystic fibrosis Eur. Respir. J., August 1, 2004; 24(2): 286 - 291. [Abstract] [Full Text] [PDF]

				M. M. Marc, P. Korosec, M. Kosnik, I. Kern, M. Flezar, S. Suskovic, and J. Sorli Complement Factors C3a, C4a, and C5a in Chronic Obstructive Pulmonary Disease and Asthma Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 216 - 219. [Abstract] [Full Text] [PDF]

				K. Parameswaran, R. Watson, G. M. Gauvreau, R. Sehmi, and P. M. O'Byrne The Effect of Pranlukast on Allergen-induced Bone Marrow Eosinophilopoiesis in Subjects with Asthma Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 915 - 920. [Abstract] [Full Text] [PDF]

				M.M. Kelly, F.E. Hargreave, and G. Cox A method to preserve sputum for delayed examination Eur. Respir. J., December 1, 2003; 22(6): 996 - 1000. [Abstract] [Full Text] [PDF]

				B. M. Saraiva-Romanholo, V. Barnabe, A. L. I. Carvalho, M. A. Martins, P. H. N. Saldiva, and M. d. P. T. Nunes Comparison of Three Methods for Differential Cell Count in Induced Sputum Chest, September 1, 2003; 124(3): 1060 - 1066. [Abstract] [Full Text] [PDF]

				R.O. Crapo, R.L. Jensen, and F.E. Hargreave Airway inflammation in COPD: physiological outcome measures and induced sputum Eur. Respir. J., June 1, 2003; 21(41_suppl): 19S - 28s. [Abstract] [Full Text] [PDF]

				T. M. A. Wilkinson, I. S. Patel, M. Wilks, G. C. Donaldson, and J. A. Wedzicha Airway Bacterial Load and FEV1 Decline in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1090 - 1095. [Abstract] [Full Text] [PDF]

				R. Leigh, D. Vethanayagam, M. Yoshida, R. M. Watson, T. Rerecich, M. D. Inman, and P. M. O'Byrne Effects of Montelukast and Budesonide on Airway Responses and Airway Inflammation in Asthma Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1212 - 1217. [Abstract] [Full Text] [PDF]

				Leader of the Working Group: A. Efthimiadis, A. Sp, Members of the Working Group:, Q. Hamid, M.M. Kelly, M. Linden, R. Louis, M.M.M. Pizzichini, E. Pizzichini, C. Ronchi, F. Van Overveld, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation Eur. Respir. J., July 1, 2002; 20(37_suppl): 19S - 23s. [Full Text] [PDF]

				Leader of the Working Group: M.M. Kelly, Members of the Working Group:, V. Keatings, R. Leigh, C. Peterson, J. Shute, P. Venge, and R. Djukanovic Analysis of fluid{-}phase mediators Eur. Respir. J., July 1, 2002; 20(37_suppl): 24S - 39s. [Full Text] [PDF]

				A. Efthimiadis, L. Jayaram, S. Weston, S. Carruthers, and F.E. Hargreave Induced sputum: time from expectoration to processing Eur. Respir. J., April 1, 2002; 19(4): 706 - 708. [Abstract] [Full Text] [PDF]

				G W Chalmers, K J Macleod, S A Little, L J Thomson, C P McSharry, and N C Thomson Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma Thorax, March 1, 2002; 57(3): 226 - 230. [Abstract] [Full Text] [PDF]

				G. W. Chalmers, K. J. MacLeod, L. Thomson, S. A. Little, C. McSharry, and N. C. Thomson Smoking and Airway Inflammation in Patients With Mild Asthma Chest, December 1, 2001; 120(6): 1917 - 1922. [Abstract] [Full Text] [PDF]

				M.M. Kelly, R. Leigh, S. Carruthers, P. Horsewood, G.J. Gleich, F.E. Hargreave, and G. Cox Increased detection of interleukin-;5 in sputum by addition of protease inhibitors Eur. Respir. J., October 1, 2001; 18(4): 685 - 691. [Abstract] [Full Text] [PDF]

				J.D. Leuppi, C.M. Salome, C.R. Jenkins, H. Koskela, J.D. Brannan, S.D. Anderson, M. Andersson, H.K. Chan, and A.J. Woolcock Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Eur. Respir. J., September 1, 2001; 18(3): 444 - 450. [Abstract] [Full Text] [PDF]

				N R Henig, M R Tonelli, M V Pier, J L Burns, and M L Aitken Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis Thorax, April 1, 2001; 56(4): 306 - 311. [Abstract] [Full Text]

				N. E. Alexis, J. Soukup, S. Nierkens, and S. Becker Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L369 - L375. [Abstract] [Full Text] [PDF]

				A. SPANEVELLO, M. CONFALONIERI, F. SULOTTO, F. ROMANO, G. BALZANO, G. B. MIGLIORI, A. BIANCHI, and G. MICHETTI Induced Sputum Cellularity . Reference Values and Distribution in Normal Volunteers Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1172 - 1174. [Abstract] [Full Text]

				N. M Wilson, P. Bridge, A. Spanevello, and M. Silverman Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity Thorax, September 1, 2000; 55(9): 768 - 774. [Abstract] [Full Text]

				A. B. Nia, L. M. Maas, S. G. J. Van Breda, D. M. J. Curfs, J. C. S. Kleinjans, E. F. M. Wouters, and F. J. Van Schooten Applicability of Induced Sputum for Molecular Dosimetry of Exposure to Inhalatory Carcinogens: 32P-Postlabeling of Lipophilic DNA Adducts in Smokers and Nonsmokers Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 367 - 372. [Abstract] [Full Text]

				M. Z. NORZILA, K. FAKES, R. L. HENRY, J. SIMPSON, and P. G. GIBSON Interleukin-8 Secretion and Neutrophil Recruitment Accompanies Induced Sputum Eosinophil Activation in Children with Acute Asthma Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 769 - 774. [Abstract] [Full Text] [PDF]

				J. BELDA, R. LEIGH, K. PARAMESWARAN, P. M. O'BYRNE, M. R. SEARS, and F. E. HARGREAVE Induced Sputum Cell Counts in Healthy Adults Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 475 - 478. [Abstract] [Full Text]

				A. Bhowmik, T. A R Seemungal, R. J Sapsford, and J. A Wedzicha Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations Thorax, February 1, 2000; 55(2): 114 - 120. [Abstract] [Full Text]

				F. E. HARGREAVE and R. LEIGH Induced Sputum, Eosinophilic Bronchitis, and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S53 - 57. [Abstract] [Full Text] [PDF]

				M. CHAN-YEUNG, H. OBATA, M. DITTRICK, H. CHAN, and R. ABBOUD Airway Inflammation, Exhaled Nitric Oxide, and Severity of Asthma in Patients with Western Red Cedar Asthma Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1434 - 1438. [Abstract] [Full Text] [PDF]

				G Woltmann, R J Ward, F A Symon, D A Rew, I D Pavord, and A J Wardlaw Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry Thorax, February 1, 1999; 54(2): 124 - 130. [Abstract] [Full Text]

				A Bhowmik, T A R Seemungal, R J Sapsford, J L Devalia, and J A Wedzicha Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease Thorax, November 1, 1998; 53(11): 953 - 956. [Abstract] [Full Text]

				R. ANDREW MCIVOR, E. PIZZICHINI, M. O. TURNER, P. HUSSACK, F. E. HARGREAVE, and M. R. SEARS Potential Masking Effects of Salmeterol on Airway Inflammation in Asthma Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 924 - 930. [Abstract] [Full Text] [PDF]

				J. BELDA, K. PARAMESWARAN, and F. E. HARGREAVE COMPARISON OF TWO METHODS OF PROCESSING INDUCED SPUTUM: SELECTED VERSUS ENTIRE SPUTUM Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 680 - 682. [Full Text] [PDF]

				K. GRÜNBERG, H. H. SMITS, M. C. TIMMERS, E. P. A. de KLERK, R. J. E. M. DOLHAIN, E. C. DICK, P. S. HIEMSTRA, and P. J. STERK Experimental Rhinovirus 16 Infection . Effects on Cell Differentials and Soluble Markers in Sputum in Asthmatic Subjects Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 609 - 616. [Abstract] [Full Text]

				A. SPANEVELLO, B. BEGHÉ, A. BIANCHI, G. B. MIGLIORI, M. AMBROSETTI, M. NERI, and P. W. IND Comparison of Two Methods of Processing Induced Sputum: Selected versus Entire Sputum Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 665 - 668. [Abstract] [Full Text]